| Date | Title | Description | Source |
| 06.03.2024 | Zymeworks Reports Fourth Quarter and Full Year 2023 Financia... | - | globenewsw... |
| 11.04.2023 | Tech Moves: Adaptive Biotechnologies COO departing; Sana add... | Mark Adams. (Adaptive Photo)
— Mark Adams is stepping down as chief operating officer of Adaptive Bi... | geekwire.c... |
| 04.02.2022 | Zymeworks : Announces Participation in Upcoming Investor Con... | Zymeworks Announces Participation in Upcoming Investor Conferences
Vancouver, Canada and Seattle, Wa... | marketscre... |
| 27.01.2022 | Zymeworks Announces Pricing of $100.0 Million Public Offerin... | Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional b... | marketscre... |
| 27.01.2022 | Selling shares at a discount, Zymeworks grabs $100M cash i... | Biotech veteran Kenneth Galbraith got the cash he wants to right the ship at Zymeworks — but not... | endpts.com... |
| 06.01.2022 | John Maraganore wanted to become a biotech granddad afte... | On his way out of Alnylam, outgoing CEO John Maraganore, who had led the biotech through thick a... | endpts.com... |
| 06.01.2022 | Longtime Zymeworks CEO, co-founder Tehrani hits the exit i... | After a down year, biopharma writ large is looking for a breath of fresh air — and now the winds... | endpts.com... |
| 10.11.2021 | Zymeworks Launches Global Phase 3 Zanidatamab Trial in First... | Zymeworks Launches Global Phase 3 Zanidatamab Trial in First-Line
HER2-Positive Gastroesophageal Ade... | marketscre... |
| 26.10.2021 | Zymeworks Announces Webcast to Present HERIZON-GEA-01 Pivota... | Zymeworks Announces Webcast to Present HERIZON-GEA-01 Pivotal Trial Design and Zanidatamab Commercia... | marketscre... |
| 13.09.2021 | Zymeworks : Announces Abstract for Zanidatamab in First-line... | Zymeworks Announces Abstract for Zanidatamab in First-line HER2-Expressing Gastroesophageal Cancers ... | marketscre... |
| 10.03.2021 | Zymeworks Announces Five Presentations at the American Assoc... | VANCOUVER, British Columbia--(BUSINESS WIRE)--Mar 10, 2021--
Zymeworks Inc. (NYSE: ZYME), a clinical... | oaoa.com/n... |
| 27.01.2020 | Zymeworks Announces Closing of US$320.8M Public Offering | VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharma... | lumiravent... |
| 22.01.2020 | Zymeworks Files Preliminary Prospectus Supplements for Offer... | VANCOUVER, British Columbia—(BUSINESS WIRE)– Zymeworks Inc. (NYSE: ZYME) (“Zymeworks” or the “Compan... | lumiravent... |
| 13.01.2020 | Zymeworks Inks Collaboration Agreement with Pfizer in Breast... | VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharma... | lumiravent... |
| 22.11.2019 | Zymeworks & BeiGene Advance ZW25 into Potentially Regist... | SINGAPORE — Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multi... | lumiravent... |
| 06.11.2019 | Zymeworks Reports Q3 2019 Financial Results | “We recently presented data on our lead asset, ZW25, at two major medical conferences that pave the ... | lumiravent... |
| 06.11.2019 | BDC spinout Amplitude Ventures closes half of newly-launched... | Amplitude Ventures, a Montréal-headquartered investment firm focused on health and the life sciences... | betakit.co... |
| 28.10.2019 | Zymeworks Releases Phase 1 Data for ZW25 at International Co... | BOSTON — Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifun... | lumiravent... |
| 17.10.2019 | Zymeworks Appoints Kathy O’Driscroll to Chief People Officer... | VANCOUVER, British Columbia — Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical compan... | lumiravent... |
| 03.10.2019 | Zymeworks Announces Updated Single Agent Data for HER2-Targe... | BARCELONA, Spain–(BUSINESS WIRE) — Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutic... | lumiravent... |
| 17.09.2019 | Lota Zoth Succeeds Nick Bedford as Chair of Zymeworks’ Board... | VANCOUVER, British Columbia — Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical co... | lumiravent... |
| 06.08.2019 | Zymeworks Releases Q2 2019 Financial Results | VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage bioph... | lumiravent... |
| 16.07.2019 | Celgene Exercises Commercial Option for Zymeworks’ Azymetric... | VANCOUVER, British Columbia–(BUSINESS WIRE) — Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biop... | lumiravent... |
| 19.06.2019 | Zymeworks Announces Pricing of $175 million Public Offering | VANCOUVER, British Columbia — Zymeworks Inc. (NYSE/TSX:ZYME), a clinical-stage biopharmaceutical com... | lumiravent... |
| 06.06.2019 | Zymeworks Appoints Accomplished Executives to Board of Direc... | VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage bioph... | lumiravent... |
| 31.05.2019 | Zymeworks Earns Milestone Payment in Merck Collaboration | VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage bioph... | lumiravent... |
| 30.05.2019 | Zymeworks’ Lead Asset, ZW25 Granted Fast Track Designation f... | VANCOUVER, British Columbia — Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical co... | lumiravent... |
| 14.05.2019 | Zymeworks Enters its First ZymeLink™ Antibody-Drug Conjugate... | VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopha... | lumiravent... |
| 07.05.2019 | Zymeworks Announces Election of Directors and Voting Results... | VANCOUVER, Canada–(BUSINESS WIRE)– Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutic... | lumiravent... |
| 03.05.2019 | Zymeworks Reports 2019 First Quarter Financial Results | VANCOUVER, British Columbia–(BUSINESS WIRE) May 2, 2019– Zymeworks Inc. (NYSE/TSX: ZYME), a clinical... | lumiravent... |
| 30.04.2019 | Zymeworks Adds Experienced Executives to Management Team to ... | VANCOUVER, British Columbia / BUSINESSWIRE/ Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopha... | lumiravent... |
| 17.01.2019 | Investigational New Drug (IND)-Submission Milestone Achieved... | VANCOUVER, British Columbia — Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical co... | lumiravent... |
| 19.09.2018 | Zymeworks Names Anthony Polverino, Ph.D., Executive Vice Pre... | September 19, 2018 06:45 AM Eastern Daylight Time | lumiravent... |
| 04.09.2018 | Zymeworks Reports IND-Submission Milestone Achieved in Lilly... | Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunction... | lumiravent... |
| 11.06.2018 | Zymeworks Closes Previously Announced Public Offering | VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopha... | lumiravent... |
| 24.04.2018 | Sofinnova leads $32.4 million round for Italy's EryDel; C... | → Having followed Milan-based EryDel and its CEO for years, Sofinnova Partners is jumping in ... | endpts.com... |
| 23.04.2018 | Zymeworks and Celgene Expand Bispecific Antibody Collaborati... | “The team at Celgene has made excellent progress developing bispecific and multifunctional therapeut... | lumiravent... |
| 04.05.2017 | Zymeworks raises $80 million CAD in IPO | After announcing plans to raise $110 million CAD in an initial public offering (IPO) last week, Vanc... | betakit.co... |
| 01.05.2017 | Term Sheet — Monday, May 1 | STARWOOD-IFICATION OF REAL ESTATE
Increasingly, venture investors view real estate as the next indus... | fortune.co... |
| 25.04.2017 | Zymeworks plans to raise $110 million from its IPO | Vancouver-based Zymeworks plans to raise $110 million from a sale of as many as 5.2 million common s... | betakit.co... |
| 03.04.2017 | Armed with deals, dollars and the promise of upcoming da... | Ali Tehrani, Zymeworks accepts@BIOTECanada Gold Leaf award (CREDIT:@biogeniusCA)
A little mo... | endpts.com... |
| 08.01.2016 | Zymeworks Announces $61.5 Million Financing to Support the C... | Zymeworks Announces $61.5 Million Financing to Support the Clinical Development of its Pipeline of A... | lumiravent... |
| 08.01.2016 | Daily funding roundup - January 8, 2016 | MyMusicTaste landed $10M; Zymeworks bagged $61.5M; Pierian closed a $9.25M funding
Blinkist, a Germa... | vator.tv/n... |
| 08.01.2016 | Zymeworks Closes US$ 61.5M Series A Mezzanine Financing | Zymeworks Inc., a Vancouver, BC, Canada-based biotherapeutics company focused on accelerating its pr... | finsmes.co... |
| 08.01.2016 | Zymeworks snags huge $61.5 USD million Series A round for it... | Vancouver-based Zymeworks, a biotherapeutics company developing protein therapeutics for the treatme... | betakit.co... |
| 21.01.2015 | Celgene, Biotech's Ace Dealmaker, Bets On Canada's Zymeworks | Celgene, the big maker of blood cancer drugs, has gained a reputation for anointing biotech startups... | forbes.com... |
| 06.09.2012 | Zymeworks Raises $11.0M in Funding | Zymeworks Inc., a Vancouver, BC, Canada-based biotherapeutics company focused on the development of ... | finsmes.co... |
| 06.09.2012 | Zymeworks Completes $11M Financing |
VANCOUVER, CANADA, Privately held biotherapeutics company announced the completion of a common sha... | vcnewsdail... |
| 22.09.2011 | Zymeworks Raises $8.1M | Zymeworks Inc., a Vancouver, BC, Canada-based biotherapeutics company focused on the development of ... | finsmes.co... |
| 22.09.2011 | Zymeworks Completes $8.1M Round |
Financing consists of a follow-on round of institutional investment by CTI Life Sciences Fund, L.P... | vcnewsdail... |
| 29.06.2010 | Zymeworks Closes $3.2M Financing | Zymeworks Inc., a Vancouver (BC), Canada-based biotechnology company focused on the development of i... | finsmes.co... |
| - | Zymeworks Reports 2020 Year-End Financial Results | VANCOUVER, Canada--(BUSINESS WIRE)--Feb 24, 2021--
Zymeworks Inc. (NYSE: ZYME), a clinical-stage bio... | oaoa.com/n... |
